PDL BioPharma, Inc. Convertible Notes Payable, Current
PDL BioPharma, Inc. had Convertible Notes Payable, Current of $0 as of 2018-12-31, per its 10-K filed 2019-03-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2019-03-15
- 2018-12-31: Convertible Notes Payable, Current $0.00.
- 2018-09-30: Convertible Notes Payable, Current $0.00.
- 2018-06-30: Convertible Notes Payable, Current $0.00.
- 2018-03-31: Convertible Notes Payable, Current $0.00.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-15 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-07 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-09 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 |
| 2017-12-31 | $126.07M 10-K · filed 2019-03-15 |
| 2017-09-30 | $124.92M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $123.79M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $122.69M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-16 |
| 2015-12-31 | $0.00 10-K · filed 2016-02-23 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-04 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-05 |
| 2015-03-31 | $154.59M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $175.50M 10-K · filed 2016-02-23 |
| 2014-09-30 | $199.67M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $197.96M 10-Q · filed 2014-08-18 |
| 2014-03-31 | $196.28M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $320.88M 10-K · filed 2015-02-23 |
| 2013-09-30 | $171.07M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $169.52M 10-Q · filed 2013-08-08 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-03 |
| 2011-03-31 | $133.46M 10-Q · filed 2011-04-28 |
| 2010-12-31 | $0.00 10-Q · filed 2011-04-28 |
| 2010-06-30 | $115.83M 10-Q · filed 2010-07-29 |
| 2009-12-31 | $200.00M 10-K · filed 2011-03-01 |